Replies to post #2373 on Immunotech Laboratories Inc (IMMB)

[NanoEE]

You want it, here it is, granted this is a study in 1999, but important none-the-less.

https://pubmed.ncbi.nlm.nih.gov/10658363/

When you have claimed something with out solid results(data), and are shut down by two two other labs over your claims, the Lab world won't jump to your aid until they see solid results. Toxicology report is probably on the bottom of the stack of more "important" reports. That is Harry's fault.

So, Enzolytics Inc.(and I use the company name not the stock ticker), has work to do to prove it self-worth towards investors.

For the combined materials from Bioclonetics and Enzolytics(prior merger), I am interested in the Clone3 material(medicine) compound structure(aka drug compound structure). Mostly in the chain structure.

[rbtree]

So I see, Elk. I became aware of ENZC's big move last fall, as it came along in lockstep with the across the board (almost) huge gains in stinky pinks. I just now followed Porgie's post stream over to IMMB, and see the same scammer behind both.

No wonder ENZC is now off its highs by over 80%. Of course the pumpers are screaming manipulation when it's obviously dilution--via toxic debt conversion.